Physician profile
James B Gray
NPI 1750397675
$3,072.92
in general payments reported to CMS, 2019-2025
15 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $85.41 · 2021: $547 · 2022: $593 · 2023: $666 · 2024: $336 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,420 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,420.35 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $660.06 | 2021-2025 | Total30, Precision 1, Dailies Total1 |
| Coopervision INC. | $421.95 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $356.09 | 2020-2025 | Acuvue |
| Topcon Healthcare, INC. | $285.28 | 2021-2025 | |
| Oyster Point Pharma, INC. | $195.18 | 2022-2024 | Tyrvaya, Ryzumvi |
| Sight Sciences, INC. | $193.69 | 2022-2025 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $144.73 | 2023-2025 | Miebo, Xiidra |
| Novartis Pharmaceuticals Corporation | $131.89 | 2019-2023 | |
| Maculogix, INC. | $131.37 | 2021 | |
| Biotissue Holdings INC. | $125.06 | 2022-2025 | |
| Shire North American Group INC | $124.65 | 2019 | |
| Sun Pharmaceutical Industries INC. | $105.76 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $95.77 | 2019 | |
| Mallinckrodt Hospital Products INC. | $89.98 | 2022 | |
| Allergan, INC. | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.